Anti-rheumatic drugs are associated with reduction of cardiovascular risk in patients with rheumatoid arthritis.

被引：0
|
作者：
van Halm, VP
Nurmohamed, MT
Twisk, JW
Dijkmans, BA
Voskuyl, AE
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Netherlands Jan Van Breemen Inst, Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S704 / S704
页数：1
相关论文
共 50 条
  • [1] Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis
    Cho, Soo-Kyung
    Kim, Dam
    Won, Soyoung
    Lee, Jiyoung
    Park, ByeongJu
    Jang, Eun Jin
    Bae, Sang-Cheol
    Sung, Yoon-Kyoung
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 47 (04) : 501 - 506
  • [2] Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
    Baoqi, Yang
    Dan, Ma
    Xingxing, Zhao
    Xueqing, Zhu
    Yajing, Wang
    Ke, Xu
    Liyun, Zhang
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [3] Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld, CHM
    Jahangier, ZN
    Jacobs, JWG
    Blaauw, AAM
    Brus, HLM
    van Albada-Kuipers, GA
    van der Veen, MJ
    Schenk, Y
    ter Borg, EJ
    Bijlsma, JWJ
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S271 - S271
  • [4] Time To Institution Of Disease Modifying Anti-Rheumatic Drugs In Australian Patients With Early Rheumatoid Arthritis.
    Van Doornum, Sharon
    Tropea, Joanne
    Tacey, Mark
    Liew, Danny
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S565 - S565
  • [5] Heart Failure Risk Among Patients with Rheumatoid Arthritis: Association with Anti-Rheumatic Drugs
    Ahlers, Michael
    Stein, C. Michael
    Chung, Cecilia P.
    Ormseth, Michelle J.
    Farber-Eger, Eric
    Gupta, Deepak
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] Effectiveness of disease modifying anti-rheumatic drug risk communication in rheumatoid arthritis.
    Martin, Richard W.
    McIntosh, Barbara A.
    Swartz, Timothy J.
    Head, Andrew J.
    Fiechtner, Justus J.
    Rene, Jonathan
    Holmes-Rovner, Margaret
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S369 - S369
  • [7] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
    Kaminski, Matthew
    Shishehbor, Mehdi H.
    Gutierrez, Antonio
    Amini, Mohammad R.
    Coats, Walter
    Moghbelli, Meisam
    Askari, Arman T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
  • [8] Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
    Giachi, Andrea
    Cugno, Massimo
    Gualtierotti, Roberta
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review
    Giollo, Alessandro
    Bissell, Lesley-Anne
    Buch, Maya H.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) : 697 - 708
  • [10] ANTI-RHEUMATIC NONSTEROID DRUGS IN THERAPY OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    DORMIDONTOV, EN
    KORSHUNOV, NI
    BARANOVA, EY
    [J]. TERAPEVTICHESKII ARKHIV, 1978, 50 (09): : 10 - 13
12345